A Partner of Choice
At Next Science, we remain committed to leading a paradigm shift in fighting bacterial infections and antimicrobial resistance with a unique and non-toxic approach to eradicating both biofilm and planktonic bacteria. As we continue to pioneer and bring to market patented break-through solutions, we are also joining forces with others to accelerate the adoption of proven solutions for addressing biofilm – from scalpel to suture.
Partner with Next Science
We continually look to forge creative business collaborations and partnerships that enhance the depth and breadth of our business and align with our mission, values and goals. We adopt a flexible, innovated partnership approach and would like to hear from you about possible opportunities. Please contact our business development team at [email protected]
Industry Partners
Zimmer Biomet
Next Science and Zimmer Biomet have partnered with an exclusive global distribution agreement for Bactisure™ Wound Lavage in the surgical space. Bactisure is a sterile, aqueous solution used to remove debris – including microorganisms – from wounds using pulsed (jet) lavage. Used as an adjunct to normal saline lavage, Bactisure is a 510(K) cleared device and is available from Zimmer Biomet globally.
Zimmer Biomet was founded in 1927 and is a global leader in musculoskeletal healthcare. Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants and related surgical products.
Advanced Skin Technology
Next Science and Advanced Skin Technology have partnered to provide a solution to help prevent problematic skin with Aspect™ Clear Skin Complex and Aspect Dr™ BHA Purifying Gel.
Advanced Skin Technology is Australia’s leading distributor of technologically advanced cosmeceutical products and treatments supplying them to Australian and New Zealand medical and skin care industry. For more than 25 years, AST has been at the forefront of the skincare industry with over 2500 clinic partners and recognized for offering industry-leading marketing support and education.
novus surgical
Oraderm Pharmaceuticals
Research Partners
Montana State University Center for Biofilm Engineering
Next Science has partnered with the Montana State University Center for Biofilm Engineering to extensively test the effectiveness of XBIO® Technology against clinically relevant biofilms.
The Mayo Clinic
Next Science has partnered with the Mayo Clinic for a clinical study on the effectiveness of Next Science BLASTX® in the treatment of chronic wounds.
Southwest Regional Wound Care Center
Next Science has partnered with Dr. Randall Wolcott at the Southwest Regional Wound Care Center for ongoing clinical testing of Next Science BLASTX® in patients with chronic wounds.
Texas Tech University Clinical Research Institute
Next Science partners with Texas Tech University to evaluate both the in vitro and in vivo efficacy of multiple applications. This includes the in vivo efficacy and cytokine responsiveness in chronic wounds being treated with BLASTX®
University of Florida Department of Otolaryngology
Next Science has partnered with the University of Florida Department of Otolaryngology to test the ototoxicity and ciliotoxicity of Next Science technology for use in Middle Ear applications.
Jacksonville Center for Clinical Research
Next Science has partnered with the Jacksonville Center for Clinical Research for clinical testing of Next Science Acne Gel in patients with moderate acne.
A Future-Forward Vision
Leveraging its composition-of-matter patents, Next Science is looking beyond the present applications of its novel XBIO® Technology to applications that will create a better tomorrow